IDEXX LABORATORIES INC /DE

IDXXReported to SECin USCIK 0000874716Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 7. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 7
Form 4 lines at IDEXX LABORATORIES INC /DE, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Kingsley Lawrence D—Option exercise—2,203 sharesSep 9, 2026Kingsley Lawrence D—Exercise · Sep 9Option exercise2,203Sep 9, 2026
Kingsley Lawrence D—Open-market sell$1,172,1782,203 sharesSep 9, 2026Kingsley Lawrence D$1,172,178Sell · Sep 9Open-market sell2,203Sep 9, 2026
Kingsley Lawrence D—Option exercise$251,5172,203 sharesSep 9, 2026Kingsley Lawrence D$251,517Exercise · Sep 9Option exercise2,203Sep 9, 2026
Emerson AndrewEVP, CFO and TreasurerOption exercise—265 sharesAug 24, 2026Emerson AndrewEVP, CFO and Treasurer—Exercise · Aug 24Option exercise265Aug 24, 2026
Emerson AndrewEVP, CFO and TreasurerAdministrativenothing paid86 sharesAug 24, 2026Emerson AndrewEVP, CFO and Treasurernothing paidAdmin · Aug 24Administrative86Aug 24, 2026